AU2011101324A4 — Improvements in and relating to colon cleansing compositions
Assigned to Norgine BV · Expires 2011-11-17 · 14y expired
What this patent protects
Abstract The invention provides a dry composition for admixture with water, wherein the composition is optionally presented in two or more parts and comprises, per litre of 5 solution to be made, the following components: (a) 85 to 115 g polyethylene glycol (PEG) having an averag…
USPTO Abstract
Abstract The invention provides a dry composition for admixture with water, wherein the composition is optionally presented in two or more parts and comprises, per litre of 5 solution to be made, the following components: (a) 85 to 115 g polyethylene glycol (PEG) having an average molecular weight of 2500 to 4500; (b) 6 to 9 g sodium sulphate; (c) 2 to 3 g sodium chloride; 10 (d) 0.5 to 1.5 g potassium chloride; (e) 5 to 15 g of an organic acid component; and (f) orange flavouring. Also provided are solutions, kits, unit doses and methods that comprise or use the 15 compositions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.